A road less travelled: Large animal models in immunological research

Nature Reviews Immunology

Volumn 3, Issue 1, 2003, Pages 79-84

  Hein, Wayne R ^a   Griebel, Philip J ^b  

^a AGRESEARCH   (New Zealand)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CELL SEPARATION; IMMUNOREGULATION; LYMPH; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION; ANIMAL; HUMAN; IMMUNOLOGY; SHEEP; SWINE;

ALLERGY AND IMMUNOLOGY; ANIMALS; HUMANS; MODELS, ANIMAL; SHEEP; SWINE;

EID: 0037271852     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri977     Document Type: Review

References (60)

1. Tang, D.-C., DeVit, M. & Johnston, S. A. Genetic immunisation is a simple method for eliciting an immune response. Nature 356, 152-154 (1992).
2. MacGregor, R. R. et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect Dis. 178, 92-100 (1998).
3. Robinson, H. L. New hope for an AIDS vaccine. Nature Rev. Immunol. 2, 239-250 (2002).
4. Babiuk, L. A., Babiuk, S. L., Loehr, B. I. & van Drunnen Littel-van den Hurk, S. Nucleic acid vaccines: research tool of commercial reality. Vet. Immunol. Immunopathol. 76, 1-23 (2000).
5. Eynon, E. E. & Flavell, R. A. Walking through the forest of transgenic models of human disease. Immunol. Rev. 169, 5-10 (1999).
6. Billingham, R. E., Brent, L. & Medawar, P. B. 'Actively acquired tolerance' of foreign cells. Nature 172, 603-606 (1953).
7. Griebel, P. J. & Hein, W. R. Expanding the role of Peyer's patches in B-cell ontogeny. Immunol. Today 17, 30-38 (1996).
8. Mutwiri, G., Bateman, C., Baca-Estrada, M. E., Snider, M. & Griebel, P. J. Immunocompetence of gut-associated lymphoid tissue in newborn lambs. Vaccine 19, 1284-1293 (2000).
9. Meeusen, E. N., Bishof, R. J. & Lee, C. S. Comparative T-cell responses during pregnancy in large animals and humans. Am. J. Reprod Immunol. 46, 169-179 (2001).
10. Swasdipan, S., McGowan, M., Phillips, N. & Bielefeldt-Ohmann, H. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. Microb. Pathog. 32, 49-60 (2002).
11. Hecht, S. J., Stedman, K. E., Carlson, J. O. & DeMartini, J. C. Distribution of endogenous type B and type D sheep retrovirus sequences in ungulates and other mammals. Proc. Natl Acad. Sci. USA 93, 3297-3302 (1996).
12. Gerdts, V., Babiuk, L. A., van Drunen Littel-van den Hurk, S. & Griebel, P. J. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nature Med. 6, 929-932 (2000).
13. Gerdts, V., Snider, M., Brownlie, R., Babiuk, L. A. & Griebel, P. J. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J. Immunol. 168, 1877-1885 (2002).
14. Hein, W. R. Sheep as experimental animals for immunological research. The Immunologist 3, 12-18 (1995).
15. Pirenne, J. Contnbution of large animal models to the development of clinical intestinal transplantation. Acta Gastroenterol. Belg. 62, 221-225 (1999).
16. Goodman, S. & Check, E. Animal experiments: the great primate debate. Nature 417, 684-687 (2002).
17. Tran, N. D. et al. In utero transfer and expression of exogenous genes in sheep. Exp. Hematol. 28, 17-30 (2000).
18. + cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras. Blood 100, 72-79 (2002).
19. Lewis, I. D. et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 97, 3441-3449 (2001).
20. Costa, C. et al. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation 9, 45-57 (2002).
21. Luo, Y. et al. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood. Xenotransplantation 9, 36-44 (2002).
22. + T-cell epitopes on the fusion (F) and attachment (G) proteins of bovine respiratory syncytial virus (BRSV). Vaccine 19, 3226-3240 (2001).
23. Karol, M. H. Animal models of occupational asthma. Eur. Resp. J. 7, 555-568 (1994).
24. Bice, D. E., Seagrave, J. & Green, F. H. Animal models of asthma: potential usefulness for studying health effects of inhaled particles. Inhal. Toxicol. 12, 829-862 (2000).
25. Buddle, B. M. Vaccination of cattle against Mycobacterium bovis. Tuberculosis 81, 125-132 (2001).
26. Orme, I. M. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? Tuberculosis 81, 109-113 (2001).
27. Buddle, B. M., Wards, B. J., Aldwell, F. E., Collins, D. M. & de Lisle, G. W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20, 1126-1133 (2002).
28. Fine, P. E. M. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345 (1995).
29. Heggebo, R. Press, C. M., Gunnes, G., Gonzalez, L. & Jeffrey, M. Distnbution and accumulation of PrP in gut-associated and peripheral lymphoid tissue of scrapie-affected Suffolk sheep. J. Gen. Virol. 83, 479-489 (2002).
30. Bauer, S. et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA 98, 9237-9242 (2001).
31. Rankin, R. et al. Identification of a stimulatory CpG motif for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11, 333-340 (2001).
32. Ceretti, D. P. et al. The murine homologue of the human interleukin-8 type receptor type-B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics 18, 410-413 (1993).
33. Pastoret, P.-P., Griebel, P., Bazin, H. & Govaerts, A. (eds) Handbook of Vertebrate Immunology (Academic Press, London, 1998).
34. Li, F., Zhang, X. & Gordon, J. R. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. Biochem. Biophys. Res. Commun. 293, 939-944 (2002).
35. Brayden, D. J. Oral vaccination in man using antigens in particles: current status. Eur. J. Pharm Sci. 14, 183-189 (2001).
36. Gerdts, V. et al. Multiple intestinal 'loops' provide an in vivo model to analyze mucosal immune responses. J. Immunol. Methods 256, 19-33 (2001).
37. Mutwiri, G. et al. Induction of mucosal immune responses following enteric immunisation with antigen delivered in alginate microspheres. Vet. Immunol. Immunopathol. 87, 269-276 (2002).
38. Hammond, S. A., Guebre-Xabier, M., Yu, J. & Glenn, G. M. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Crit. Rev. Ther. Drug Carrier Syst. 18, 503-526 (2001).
39. Glenn, G. M. et al. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nature Med. 6, 1403-1406 (2000).
40. Hammond, S. A. et al. Transcutaneous immunisation of domestic animals: opportunities and challenges. Adv. Drug Delivery Rev. 43, 45-55 (2000).
41. Lunney, J. K., Fossum, C., Alm, G. V., Steinbach, F. & Wattrang, E. Veterinary immunology: opportunities and challenges. Trends Immunol. 23, 4-6 (2002).
42. Hein, W. R. & Mackay, C. R. Prominence of γδ T cells in the ruminant immune system. Immunol. Today 12, 30-34 (1991).
43. Zuckermann, F. A. Extrathymic CD4/CD8 double positive T cells. Vet. Immunol. Immunopathol. 72, 55-66 (1999).
44. Binns, R. M. & Pabst, R. Lymphoid tissue structure and lymphocyte trafficking in the pig. Vet. Immunol. Immunopathol. 43, 79-87 (1994).
45. Check, E. Priorities for genome sequencing leave macaques out in the cold. Nature 417, 473-474 (2002).
46. Tatlow, D., Brownlie, R., Babiuk, L. A. & Griebel, P. Differential display analysis of gene expression dunng the induction of mucosal immunity. Immunogenetics 52, 73-80 (2000).
47. Campbell, K. H., McWhir, J., Ritchie, W. A. & Wilmut, I. Sheep cloned by nuclear transfer from a cultured cell Nature 380, 64-66 (1996).
48. Dinnyes, A., De Sousa, P., King, T. & Wilmut, I. Somatic cell nuclear transfer: recent progress and challenges. Cloning Stem Cells 4, 81-90 (2002).
49. Campbell, K. H. Transgenic sheep from cultured cells. Methods Mol. Biol. 180, 289-301 (2002).
50. Denning, C. et al. Deletion of the α(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nature Biotechnol. 19, 559-562 (2001).
51. Zinkernagel, R. M. What is missing in immunology to understand immunity? Nature Immunol. 1, 181-185 (2001).
52. Marozin, S. et al. Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J. Gen. Virol. 83, 735-745 (2002).
53. Olsen, C. W. DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. Vet. Microbiol. 22, 149-164 (2000).
54. Griffin, J. F., Chinn, D. N., Rodgers, C. R. & Mackintosh, C. G. Optimal models to evaluate the protective efficacy of tuberculosis vaccines. Tuberculosis 81, 133-139 (2001).
55. Bradley, R. Bovine spongiform encephalopathy and its relationship to the new variant form of Creutzfeldt-Jakob disease. Contrib. Microbiol. 7, 105-144 (2001).
56. Shanahan, F. Crohn's disease. Lancet 359, 62-69 (2002).
57. Lefebvre, L. et al. Oncoviral leukaemia virus G4 and human T-cell leukaemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J. Virol. 76, 1400-1414 (2002).
58. 3 blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am. J. Respir. Crit. Care Med. 162, 603-611 (2000).
59. Yuan, L. & Saif, L. J. Induction of mucosal immune responses and protection against entenc viruses: rotavirus infection of gnotobiotic pigs as a model. Vet. Immunol. Immunopathol. 87, 147-160 (2002).
60. Ijaz, M. K. et al. Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4. Vaccine 16, 916-920 (1998).